Table 1 General characteristics of the included studies
First author, pub. year | Study type | Country | No. of patients | Age, mean | Gender, male (%) | Surgery | Variable | Outcome measured |
|---|---|---|---|---|---|---|---|---|
da Silva et al., 2018 [23] | Prospective | Brazil | 50 | 62.8 | 64 | Isolated valve replacement and/or CABG | PA and HGS | • ICU LOS • Hospital LOS |
Fountotos et al., 2021 [25] | Prospective | Canada | 1245 | 74 | 70 | Isolated valve replacement and/or CABG | HGS | • 1-year mortality • 30-day mortality • Prolonged length of stay defined by STS (≥ 14 days) |
Mullie et al., 2018 [21] | Prospective | Canada | 277 | 71 | 75 | Isolated valve replacement and/or CABG | PA | • All‐cause mortality • 30‐day mortality • Composite major morbidity defined by the STS • Hospital LOS |
Panagidi et al., 2022 [26] | Prospective | Greece | 195 | 67.18 | 76.9 | Isolated valve replacement and/or CABG | Combined PA and HGS | • All-cause mortality • ICU LOS |
Ringaitiene et al., 2016 [27] | Prospective | Lithuania | 342 | 65 | 65.8 | Isolated valve replacement and/or CABG | PA | • Composite major morbidity defined by the STS • ICU LOS • Hospital LOS |
Ryz et al., 2022 [28] | Prospective | Austria | 168 | 65.9 | 66.1 | Elective cardiac surgery | PA | • ICU LOS |
Tsaousi et al., 2021 [29] | Prospective | Greece | 179 | 67 | 77.6 | Isolated valve replacement and/or CABG | PA and HGS | • In hospital LOS |
Visser et al., 2012 [30] | Prospective | Netherlands | 325 | 66.2 | 72.3 | Isolated valve replacement and/or CABG | PA | • ICU LOS • Hospital LOS • Mortality |